718 related articles for article (PubMed ID: 23454345)
1. Biodiversity of small molecules--a new perspective in screening set selection.
Petrone PM; Wassermann AM; Lounkine E; Kutchukian P; Simms B; Jenkins J; Selzer P; Glick M
Drug Discov Today; 2013 Jul; 18(13-14):674-80. PubMed ID: 23454345
[TBL] [Abstract][Full Text] [Related]
2. Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity.
Sukuru SC; Jenkins JL; Beckwith RE; Scheiber J; Bender A; Mikhailov D; Davies JW; Glick M
J Biomol Screen; 2009 Jul; 14(6):690-9. PubMed ID: 19531667
[TBL] [Abstract][Full Text] [Related]
3. Efficient search of chemical space: navigating from fragments to structurally diverse chemotypes.
Wassermann AM; Kutchukian PS; Lounkine E; Luethi T; Hamon J; Bocker MT; Malik HA; Cowan-Jacob SW; Glick M
J Med Chem; 2013 Nov; 56(21):8879-91. PubMed ID: 24117015
[TBL] [Abstract][Full Text] [Related]
4. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
5. Active-learning strategies in computer-assisted drug discovery.
Reker D; Schneider G
Drug Discov Today; 2015 Apr; 20(4):458-65. PubMed ID: 25499665
[TBL] [Abstract][Full Text] [Related]
6. How diverse are diversity assessment methods? A comparative analysis and benchmarking of molecular descriptor space.
Koutsoukas A; Paricharak S; Galloway WR; Spring DR; Ijzerman AP; Glen RC; Marcus D; Bender A
J Chem Inf Model; 2014 Jan; 54(1):230-42. PubMed ID: 24289493
[TBL] [Abstract][Full Text] [Related]
7. Rethinking molecular similarity: comparing compounds on the basis of biological activity.
Petrone PM; Simms B; Nigsch F; Lounkine E; Kutchukian P; Cornett A; Deng Z; Davies JW; Jenkins JL; Glick M
ACS Chem Biol; 2012 Aug; 7(8):1399-409. PubMed ID: 22594495
[TBL] [Abstract][Full Text] [Related]
8. Plate-based diversity subset screening generation 2: an improved paradigm for high-throughput screening of large compound files.
Bell AS; Bradley J; Everett JR; Loesel J; McLoughlin D; Mills J; Peakman MC; Sharp RE; Williams C; Zhu H
Mol Divers; 2016 Nov; 20(4):789-803. PubMed ID: 27631533
[TBL] [Abstract][Full Text] [Related]
9. Hit finding: towards 'smarter' approaches.
Langer T; Hoffmann R; Bryant S; Lesur B
Curr Opin Pharmacol; 2009 Oct; 9(5):589-93. PubMed ID: 19576852
[TBL] [Abstract][Full Text] [Related]
10. Expanding the medicinally relevant chemical space with compound libraries.
López-Vallejo F; Giulianotti MA; Houghten RA; Medina-Franco JL
Drug Discov Today; 2012 Jul; 17(13-14):718-26. PubMed ID: 22515962
[TBL] [Abstract][Full Text] [Related]
11. Early phase drug discovery: cheminformatics and computational techniques in identifying lead series.
Duffy BC; Zhu L; Decornez H; Kitchen DB
Bioorg Med Chem; 2012 Sep; 20(18):5324-42. PubMed ID: 22938785
[TBL] [Abstract][Full Text] [Related]
12. The opportunities of mining historical and collective data in drug discovery.
Wassermann AM; Lounkine E; Davies JW; Glick M; Camargo LM
Drug Discov Today; 2015 Apr; 20(4):422-34. PubMed ID: 25463034
[TBL] [Abstract][Full Text] [Related]
13. Visual characterization and diversity quantification of chemical libraries: 1. creation of delimited reference chemical subspaces.
Le Guilloux V; Colliandre L; Bourg S; Guénegou G; Dubois-Chevalier J; Morin-Allory L
J Chem Inf Model; 2011 Aug; 51(8):1762-74. PubMed ID: 21761916
[TBL] [Abstract][Full Text] [Related]
14. Mining for bioactive scaffolds with scaffold networks: improved compound set enrichment from primary screening data.
Varin T; Schuffenhauer A; Ertl P; Renner S
J Chem Inf Model; 2011 Jul; 51(7):1528-38. PubMed ID: 21615076
[TBL] [Abstract][Full Text] [Related]
15. Bioturbo similarity searching: combining chemical and biological similarity to discover structurally diverse bioactive molecules.
Wassermann AM; Lounkine E; Glick M
J Chem Inf Model; 2013 Mar; 53(3):692-703. PubMed ID: 23461561
[TBL] [Abstract][Full Text] [Related]
16. Cheminformatics approaches to analyze diversity in compound screening libraries.
Akella LB; DeCaprio D
Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
[TBL] [Abstract][Full Text] [Related]
17. Stratified high-throughput screening sets enable flexible screening strategies from a single plated collection.
Nissink JW; Schmitt S; Blackburn S; Peters S
J Biomol Screen; 2014 Mar; 19(3):369-78. PubMed ID: 23918919
[TBL] [Abstract][Full Text] [Related]
18. The European Lead Factory: An updated HTS compound library for innovative drug discovery.
van Vlijmen H; Ortholand JY; Li VM; de Vlieger JSB
Drug Discov Today; 2021 Oct; 26(10):2406-2413. PubMed ID: 33892142
[TBL] [Abstract][Full Text] [Related]
19. Chemical and biological properties of frequent screening hits.
Che J; King FJ; Zhou B; Zhou Y
J Chem Inf Model; 2012 Apr; 52(4):913-26. PubMed ID: 22435989
[TBL] [Abstract][Full Text] [Related]
20. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
Bergsdorf C; Ottl J
Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
